Interferon-alfa With or Without Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Newly Diagnosed Chronic Myelogenous Leukemia

NCT00002868 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

744

Enrollment

NETWORK

Sponsor class

Conditions

Leukemia

Interventions

BIOLOGICAL: filgrastim
BIOLOGICAL: recombinant interferon alfa
DRUG: busulfan
DRUG: cytarabine
DRUG: etoposide
DRUG: hydroxyurea
DRUG: idarubicin
PROCEDURE: peripheral blood stem cell transplantation

Sponsor

Eastern Cooperative Oncology Group

Collaborators

[object Object]